MedPath

Comparison of the effect of treatment with HCG and recombinant human FSH versus not treatment on improvement of semen parameters in infertile men after surgical repair of varicocele

Phase 3
Conditions
Male infertility due to varicocele.
Male infertility
Registration Number
IRCT201203039014N3
Lead Sponsor
Vic-Chancellor of Research and Technology, Hamadan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
94
Inclusion Criteria

Inclusion criteria are: (a) having unilateral or bilateral palpable varicocele; (b) history of infertility for at least one-year; (c) having healthy wife; having abnormal spermogram.
Exclusion criteria are: (a) having no testis in scrotum; (b) having acute urogenital infection; (c) medical history of abnormal function of testis such as: trauma, torsion, cryptorchidism, vas deferens obstruction, abnormal karyotype, diabetes, chemotherapy, any history of surgical treatment on testis, scrotum or pituitary gland; (d) contraindication of FSH such as high level of FSH in serum or uncontrolled dysfunction of thyroid or adrenal glands; (e) BMI>40; (f) substance abuse such as alcohol, narcotics, or anabolic asteroids; (g) testis smaller than 4 mL in ultrasonography; (h) azoospermia (no spermatozoid); (i) using gonadotropin.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The outcome of interest is improvement of the semen parameters including concentration (106/mm2), motility (%), and morphology (%) of spermatozoid. Timepoint: Three months. Method of measurement: Laboratory tests.
Secondary Outcome Measures
NameTimeMethod
The secondary outcome of interest is the increase in the rate of pregnancy and decrease in the duration of waiting time for pregnancy. Timepoint: One year. Method of measurement: History taking.
© Copyright 2025. All Rights Reserved by MedPath